Krane Funds Advisors LLC Trims Position in The Procter & Gamble Company (NYSE:PG)

Krane Funds Advisors LLC lessened its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 82.2% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 302 shares of the company’s stock after selling 1,397 shares during the period. Krane Funds Advisors LLC’s holdings in Procter & Gamble were worth $52,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Acorn Creek Capital LLC increased its position in shares of Procter & Gamble by 2.8% during the third quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock worth $376,000 after acquiring an additional 59 shares during the last quarter. Alera Investment Advisors LLC raised its position in shares of Procter & Gamble by 1.2% in the 1st quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock valued at $812,000 after purchasing an additional 60 shares in the last quarter. Hudson Value Partners LLC boosted its stake in shares of Procter & Gamble by 4.1% during the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock valued at $250,000 after buying an additional 60 shares during the last quarter. Traveka Wealth LLC grew its position in shares of Procter & Gamble by 1.7% during the third quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock worth $616,000 after buying an additional 60 shares in the last quarter. Finally, Fiduciary Alliance LLC increased its stake in shares of Procter & Gamble by 2.8% in the second quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock worth $371,000 after buying an additional 61 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insider Buying and Selling at Procter & Gamble

In other news, insider Susan Street Whaley sold 634 shares of the firm’s stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the sale, the insider now directly owns 19,341 shares of the company’s stock, valued at $3,319,882.65. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other Procter & Gamble news, insider Susan Street Whaley sold 634 shares of the company’s stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the sale, the insider now directly owns 19,341 shares of the company’s stock, valued at approximately $3,319,882.65. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Andre Schulten sold 13,041 shares of Procter & Gamble stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the transaction, the chief financial officer now directly owns 37,208 shares in the company, valued at approximately $6,325,360. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 383,194 shares of company stock valued at $65,140,718. Corporate insiders own 0.17% of the company’s stock.

Procter & Gamble Stock Performance

PG opened at $172.24 on Friday. The business has a 50 day moving average price of $171.75 and a two-hundred day moving average price of $167.04. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53. The company has a market capitalization of $406.51 billion, a price-to-earnings ratio of 28.14, a price-to-earnings-growth ratio of 3.67 and a beta of 0.41. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, beating the consensus estimate of $1.37 by $0.03. The business had revenue of $20.53 billion during the quarter, compared to analyst estimates of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The company’s revenue was down .1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.37 earnings per share. Research analysts predict that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a $1.0065 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.34%. Procter & Gamble’s dividend payout ratio (DPR) is 65.69%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on PG shares. Wolfe Research raised shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. StockNews.com lowered Procter & Gamble from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a report on Thursday, August 29th. Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Finally, Stifel Nicolaus raised their price objective on Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a research note on Monday, July 22nd. Nine analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average target price of $176.21.

View Our Latest Research Report on Procter & Gamble

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Recommended Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.